Insider Trading & Ownership of Lawrence Otto Klein

Location: Menlo Park, CA
Summary: The estimated net worth of Lawrence Otto Klein is at least $38,527,192 dollars as of 17 Mar 2026. Lawrence Otto Klein is the Chief Executive Officer, Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $38.3M. Lawrence Otto Klein is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $229.3K.
Signature: /s/ Paul Quinlan, as attorney-in-fact for Lawrence Klein
All Insider Reports: All Insider Reports

Notify me when Lawrence Otto Klein files a new Insider Trading report.

Ownership of Lawrence Otto Klein

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ORKA	Oruka Therapeutics, Inc.	Chief Executive Officer, Director	$38,297,861	-$71,408	-0.19%	16 Mar 2026
JBIO	Aerovate Therapeutics, Inc.	Director	$229,331			29 Apr 2025
CRSP	CRISPR Therapeutics AG	Cbo & Coo				16 Aug 2022
DYN	Dyne Therapeutics, Inc.	Director				05 Jul 2022
JSPR, JSPRW	Jasper Therapeutics, Inc.	Director				07 Jun 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.